Experience

AptaTargets

• Spain
• Biotechnology Research
• 1 - 100 Employee

• CEO

  • Mar 2017 - Present

  AptaTargets is a biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept. AptaTargets is a biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept.



Growth Factor Biocapital GFB

• Biotechnology Research

• Partner

  • Jul 2013 - Present

  GFB is an investment platform focused on Spanish biotechnology industry. Our goal is to invest in a portfolio of companies in early-stage development or facing growth. GFB is an investment platform focused on Spanish biotechnology industry. Our goal is to invest in a portfolio of companies in early-stage development or facing growth.



SAUSALITO CAPITAL

• United States
• Real Estate
• 1 - 100 Employee

• Partner

  • Jan 2007 - Present

  Analysis and investment in biotechnology projects. SAUSALITO currently holds and manages equity shares in biotechnology companies in Spain. Analysis and investment in biotechnology projects. SAUSALITO currently holds and manages equity shares in biotechnology companies in Spain.



Aptus Biotech

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Co-Founder and Board Member

  • Oct 2010 - Jun 2017

  Aptus Biotech is a biotech start-up founded in 2010 from a collaboration agreement with the Ramon y Cajal Hospital Foundation.Our goal is to become a leading start-up in the development of new biotechnological applications based on aptamers. Aptus management and technical team are also supported by Ramon y Cajal Foundation team, with an extensive experience in research and biomedical applications. APTUS Biotech offers aptamer selection services: oligonucleotide Selection by SELEX method, aptamer storage through its insertion in bacteria, chemical synthesis of aptamers and binding studies with target proteins.Aptamers are olygonucleotides capable of identifying a target molecule with high affinity and specificity, which grants them enormous potential as therapeutic and diagnostic tools.



IGEN Biotech

• Spain
• Biotechnology
• 1 - 100 Employee

• General Manager

  • Jan 2007 - Nov 2016

  IGEN Biotech is a privately owned company focused on R&D in the biomedical field. Its aim is to put into practice biomedical research development and bring it to the market as products and services. Its main field is development of new diagnostic methods, drugs and other therapeutic methods, focusing on the use of genomic, proteomic and cell therapy.As a basis of its strategy, IGEN collaborates with R&D centers of reference, both public and private. This results in innovative and quality proposals being added to our projects portfolio.Our goal is to actively participate in the R&D stages, providing research guidelines that will help achieve practical outcomes that can be transformed into innovative goods and services with market demand.



IVI SIGLO XXI

• Business Unit General Manager

  • Jan 2002 - Dec 2006

  Real Estate investment funds. Real Estate investment funds.



Arthur D. Little

• Belgium
• Business Consulting and Services
• 700 & Above Employee

• Senior Consultant

  • Jul 2000 - Dec 2001

  Management consulting in trhe following industries: chemicals, manufacturing and transportation. Management consulting in trhe following industries: chemicals, manufacturing and transportation.



Acciona

• Spain
• Utilities
• 700 & Above Employee

• Project Manager

  • Jul 1994 - Jul 1998

  Project Manager Project Manager